Life sciences startups looking for real estate are entering a vastly different market than existed in 2022, and they have changed their leasing strategies as a result. Companies are more hesitant to leave incubator spaces and sign new leases, and they are delaying expansions and taking smaller spaces to preserve capital as funding has remained slow, industry experts said last week at Bisnow's Boston Life Sciences Conference at the Seaport Hotel. 
"We've seen that people really want to extend their runway by staying within that [incubator] system as long as possible," LabCentral Chief Operating Officer Maggie O'Toole said. "The bottom line, when you boil it all down, it is more beneficial to stay in that incubator… Read the full story here. | 
